[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340576-105":59,"doc-detail-340576-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","structure-and-function-of-the-lysine-methyltransferase-setd2-in-cancer-from-histones-to-cytoskeleton","Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton","","SETD2 is the key histone lysine methyltransferase that generates H3K36me3, a chromatin mark essential for transcriptional activation and elongation, DNA repair, mRNA splicing, and DNA methylation. Cancer commonly features recurrent SETD2-inactivating mutations together with altered H3K36me3 levels, supporting a tumor-suppressor role. Beyond epigenetics, SETD2 can methylate non-histone proteins such as cytoskeletal components tubulin and actin, thereby influencing cytoskeleton architecture, mitosis, and cell migration. This review synthesizes SETD2 functions across cancers with emphasis on structural bases and non-epigenetic contributions.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/structure-and-function-of-the-lysine-methyltransferase-setd2-in-cancer-from-histones-to-cytoskeleton/340576/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/structure-and-function-of-the-lysine-methyltransferase-setd2-in-cancer-from-histones-to-cytoskeleton/340576.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What catalytic activity does SETD2 perform on histone H3?","Question",{"text":112,"@type":113},"SETD2 uniquely trimethylates lysine 36 of histone H3 to generate H3K36me3.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is SETD2 implicated in cancer?",{"text":117,"@type":113},"Recurrent SETD2-inactivating mutations and altered H3K36me3 levels occur frequently in cancer, and studies indicate SETD2 acts as a tumor suppressor.",{"name":119,"@type":110,"acceptedAnswer":120},"How can SETD2 affect the cytoskeleton beyond epigenetics?",{"text":121,"@type":113},"SETD2 methylates non-histone cytoskeletal proteins, particularly tubulin and actin, with downstream effects on cytoskeleton structure, mitosis, and cell migration.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340576,1790183908,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","Neoplasia 59 (2025) 101090  \nContents lists available at ScienceDirect  \nNeoplasia  \njournal [homepage:](homepage: www.elsevier.com/locate/neo)[ www.elsevier.com/locate/neo](homepage: www.elsevier.com/locate/neo)  \n| Review Article\u003Cbr>Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton\u003Cbr>* *\u003Cbr>Christina Michail , Fernando Rodrigues Lima , Mireille Viguier , Fr´ed´erique Deshayes\u003Cbr>Universit´e Paris Cit´e, CNRS, Unit´e de Biologie Fonctionnelle et Adaptative, F-75013 Paris, France |  |  | |\n| --- | --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords:\u003Cbr>Cancer Cytoskeleton Genetic alterations Histones\u003Cbr>SETD2\u003Cbr>Structure |  | SETD2 is known to be the unique histone methyltransferase responsible for the trimethylation of the lysine 36 of histone H3 thus generating H3K36me3. This epigenetic mark is critical for transcriptional activation and elongation, DNA repair, mRNA splicing, and DNA methylation. Recurrent SETD2-inactivating mutations and altered H3K36me3 levels are found in cancer at high frequency and numerous studies indicate that SETD2 acts as a tumor suppressor. Recently, SETD2 was further shown to methylate non-histone proteins particularly the cytoskeletal proteins tubulin and actin with subsequent impacts on cytoskeleton structure, mitosis and cell migration.\u003Cbr>Herein, we provide a review of the role of SETD2 in different cancers with special emphasis on the structural basis of the functions of this key lysine methyltransferase. Moreover, beyond the role of this enzyme in epigenetics and H3K36me3-dependent processes, we highlight the putative role of \"non-epigenetic/H3K36me3\"functions of SETD2 in cancer, particularly those involving the cytoskeleton. |  |\n\nIntroduction  \nThe methyltransferase SET (Su(var) 3-9) Enhancer of zest and Trithorax) domain-containing 2 (SETD2) is involved in the epigenetic modification of histone H3. More specifically, SETD2 is the unique trimethyltransferase specific for lysine 36 (H3K36me3). In yeast, it is also known to mono- and di-methylate H3K36. However, this activity was not found in vivo in mammals albeit such activity has been reported using in vitro conditions [1]. SETD2 was initially described to bind Huntingtin, and the complex between SETD2 and Huntingtin was then demonstrated to be essential for the translocation of SETD2 from the nucleus to the cytoplasm [2]. SETD2 is ubiquitous, non-redundant, exclusive of H3K36 in nucleosomes and its genetic invalidation is lethal at the embryonic stage and deleterious for the development of the vascular system [3]. SETD2 is involved in various aspects of the control of gene expression (activation and repression of transcription, or even repression of initiation of cryptic transcription [4]) as well as splicing, DNA repair and DNA methylation through its lysine methylation activity and through protein-protein interactions e.g. with DNA, histones and other proteins forming platforms at nucleosomes [5].  \nSETD2 is a Protein Lysine Methyltransferases (PKMTs) that catalyze histone and non-histone methylation at lysine residues. In humans, a  \nsuper-family of approximately 50 PKMTs shares a 130 residues SET domain catalyzing lysine methylation. An important feature of the SET domain is the presence of distinct but closely related substrate and Sadenosyl-L-methionine (SAM) binding regions, which enable the transfer of the methyl group by a nucleophilic substitution (SN2) mechanism [6,7].  \nSurrounding the SET domain, two Cysteine-rich subdomains have been identified as essential for enzymatic activity (probably mostly by stabilising the SET domain structure) (Fig. 1). Interestingly, despite the importance of these subdomains, they are not strictly conserved within the SET PKMTs super-family [8]. At the C-terminal end of the SET domain of SETD2, a post-SET domain is present and is also required for optimal catalytic activity. The N-terminal side of the SET domain is ","cbCaikP7W092ZLZE","https://ap.wps.com/l/cbCaikP7W092ZLZE","pdf",6568479,14,"English","# Introduction\n## SETD2 as an epigenetic and catalytic lysine methyltransferase\n## Structural domains and interaction platforms of SETD2","[{\"question\":\"What catalytic activity does SETD2 perform on histone H3?\",\"answer\":\"SETD2 uniquely trimethylates lysine 36 of histone H3 to generate H3K36me3.\"},{\"question\":\"How is SETD2 implicated in cancer?\",\"answer\":\"Recurrent SETD2-inactivating mutations and altered H3K36me3 levels occur frequently in cancer, and studies indicate SETD2 acts as a tumor suppressor.\"},{\"question\":\"How can SETD2 affect the cytoskeleton beyond epigenetics?\",\"answer\":\"SETD2 methylates non-histone cytoskeletal proteins, particularly tubulin and actin, with downstream effects on cytoskeleton structure, mitosis, and cell migration.\"}]","Structure and function of the lysine methyltransferase SETD2 in cancer: From histones to cytoskeleton | PDF",1790037475,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b10c9cc299203ad3b77796afcac92a4e.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/01e95c7e0a18f20d48ca37294f461c59.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/330d32b37951f55ec14014cdda4fd7d5.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f43378e2e5ab535abfa441b3b8e5040.webp",980,1306]